PROSPECTS OF USING PHYTOTHERAPY AT DISORDERS OF FAT AND CARBOHYDRATE METABOLISM
Abstract
The review describes the first stage of phyto-pharmacological screening. It includes literature data analysis on promising species of medicinal plant raw materials, total extracts and individual substances of plant origin with pronounced pharmacological activity in disorders of fat and carbohydrate metabolism, incl. obesity, diabetes mellitus type 2, metabolic syndrome, and non-alcoholic fatty liver disease, confirmed in preclinical and/or clinical trials.
About the Authors
M. N. Povydysh
Saint-Petersburg State Chemical and Pharmaceutical University
Russian Federation
Russian Federation
V. G. Luzhanin
Saint-Petersburg State Chemical and Pharmaceutical University
Russian Federation
Russian Federation
D. Yu. Ivkin
Saint-Petersburg State Chemical and Pharmaceutical University
Russian Federation
Russian Federation
M. V. Belousov
Siberian State Medical University
Russian Federation
Russian Federation
G. P. Yakovlev
Saint-Petersburg State Chemical and Pharmaceutical University
Russian Federation
Russian Federation
References
1. Newman D. J., Cragg G. M. Natural products as sources of new drugs from 1981 to 2014 // J. Nat. Prod. 2016. Т. 79. № 3. Р. 629-661.
2. Newman D. J., Cragg G. M., Snader K. M. The influence of natural products upon drug discovery // Natural product reports. 2000. V. 17. № 3. Р. 215-234.
3. Aslam M. S., Ahmad M. S. Worldwide importance of medicinal plants: current and historical perspectives // Recent Adv. Biol. Med. 2016. V. 2. Р. 88-93.
4. Kalmykov S., Kalmykova Yu. Description of medicinal plants used in phytotherapy of type 2 diabetes mellitus // Slobozhansky science and sports journal. 2016. № 3(53). S. 53-58.
5. Sheweita S. A. et al. Changes in oxidative stress and antioxidant enzyme activities in streptozotocin-induced Diabetes mellitus in rats: Role of Alhagi maurorum extracts // Oxidative medicine and cellular longevity. 2016. V. 2016. P. 8.
6. Lui T. N. et al. Activation of imidazoline I 2B receptors is linked with AMP kinase pathway to increase glucose uptake in cultured C 2 C 12 cells // Neuroscience letters. 2010. V. 474. № 3. Р. 144-147.
7. Lupak M. I. et al. The alkaloid-free fraction from Galega officinalis extract prevents oxidative stress under experimental diabetes mellitus // Ukrainian biochemical journal. 2015. V. 87. № 4. Р. 78-86.
8. Ostanova H. A., Prjahina H. I. Some pharmacological properties of the aerial part of Galega officinalis L. and G. orientalis Lam // Plant resources. 2003. T. 39. № 4. S. 119-129.
9. Jakimova T. V. i dr. Hypoglycemic action of extract from Galega officinalis (Fabaceae), cultivated in Altai // Plant resources. 2005. T. 41. № 2. S. 134-138.
10. Lui T. N. et al. Activation of imidazoline I2B receptors is linked with AMP kinase pathway to increase glucose uptake in cultured C2C12 cells //Neuroscience letters. - 2010. V. 474. № 3. Р. 144-147.
11. Christensen K. B. et al. Identification of plant extracts with potential antidiabetic properties: effect on human peroxisome proliferator-activated receptor (PPAR), adipocyte differentiation and insulin-stimulated glucose uptake // Phytotherapy research. 2009. V. 23. № 9. Р. 1316-1325.
12. Palit P., Furman B. L., Gray A. I. Novel weight reducing activity of Galega officinalis in mice // Journal of pharmacy and pharmacology. 1999. V. 51. № 11. Р. 1313-1319.
13. Mooney M. H. et al. Mechanisms underlying the metabolic actions of galegine that contribute to weight loss in mice // British journal of pharmacology. 2008. V. 153. № 8. Р. 1669-1677.
14. Coxon G. D. et al. Benzylguanidines and other galegine analogues inducing weight loss in mice // Journal of medicinal chemistry. 2009. V. 52. № 11. Р. 3457-3463.
15. Plechishhik E. D., Goncharova l. V., Spiridovich E. V., Reshetnikov V. N. Fenugreek (Trigonella foenum graecum L.) as a source of a wide range of biologically active compounds // Proceedings of BSU. 2010. V. 4(2). S. 1-9.
16. Plant resources of Russia. V. 4. Families Of Caprifoliaceae – Lobeliaceae. Ed. by L. A. Budantseva, SPb.; Goods- scientific publications of KMC, 630 p.
17. Barrett M. L., Udani J. K. A proprietary alpha-amylase inhibitor from white bean (Phaseolus vulgaris): a review of clinical studies on weight loss and glycemic control // Nutrition Journal. - 2011. V. 10. № 1. Р. 24.
18. Spadafranca A. et al. Phaseolus vulgaris extract affects glycometabolic and appetite control in healthy human subjects // British Journal of Nutrition. 2013. V. 109. № 10. P. 1789-1795.
19. Tan Y., Chang S. K. C., Zhang Y. Comparison of α-amylase, α-glucosidase and lipase inhibitory activity of the phenolic substances in two black legumes of different genera // Food chemistry. 2017. V. 214. P. 259-268.
20. Mojica L., de Mejía E. G. Optimization of enzymatic production of anti-diabetic peptides from black bean (Phaseolus vulgaris L.) proteins, their characterization and biological potential // Food & function. 2016. V. 7. № 2. P. 713-727.
21. Lomas-Soria C. et al. Cooked common beans (Phaseolus vulgaris L.) modulate renal genes in streptozotocin-induced diabetic rats //The Journal of nutritional biochemistry. 2015. V. 26. № 7. P. 761-768.
22. Okada Y., Okada M., Sagesaka Y. Screening of dried plant seed extracts for adiponectin production activity and tumor necrosis factor-alpha inhibitory activity on 3T3-L1 adipocytes // Plant foods for human nutrition. 2010. V. 65. № 3. P. 225-232.
23. Rastitel’nye resursy Rossii. Dikorastushhie cvetkovye rastenija, ih komponentnyj sostav i biologicheskaja aktivnost’. T. 5. Semejstvo Asteraceae (Compositae). Chast’ 1. Rody Achillea- Doronicum / Pod red. Budanceva A. L. - SPb.: Tovarishhestvo nauchnyh izdanij KMK. 320 s.
24. Hosseini M., Asgary S., Najafi S. Inhibitory potential of pure isoflavonoids, red clover, and alfalfa extracts on hemoglobin glycosylation // ARYA atherosclerosis. 2015. V. 11. № 2. P. 133.
25. Rastitel’nye resursy Rossii. T. 3. Semejstva Fabaceae - Apiaceae / Pod red. Budanceva A. L. - SPb.: Tovarishhestvo nauchnyh izdanij KMK. 604 s.
26. Mahato S. B., Garai S. Triterpenoid saponins // Fortschritte der Chemie organischer Naturstoffe // Progress in the Chemistry of Organic Natural Products. - Vienna: Springer, 1998. P. 1-196.
27. Dushkin et al. Effects of rhaponticum carthamoides versus glycyrrhiza glabra and punica granatum extracts on metabolic syndrome signs in rats // BMC Complementar y and Alternative Medicine. 2014. V. 14. P. 33.
28. Baghernya M., Nobili V., Blesso C. N., Sahebkar A. Medicinal plants and bioactive natural compounds in the treatment of non-alcoholic fatty liver disease: a clinical review // Pharmacological Research. 2017.
29. Ya-Ling Liu, Lei-Chen Lin, Yu-Tang Tung, Shang-Tse Ho, Yao-Li Chen, Chi-Chen Lin, Jyh-Horng Wu. Rhododendron oldhamii leaf extract improves fatty liver syndrome by increasing lipid oxidation and decreasing the lipogenesis pathway in mice // International Journal of Medical Sciences. 2017. V. 14(9). P. 862-870.
30. Li N. Y., Li X. L., Zhai X. P., Wang Q. Y., Zhang X. W., Zhao F., Wang X. F., Fan J. Y., Bai F., Yu J. Effects of Mongolia Astragali Radix in protecting early cardiac and nephritic functions of patients of hypertension with metabolic syndrome // Zhongguo Zhong Yao Za Zhi. 2016 V. 41(21). P. 4051-4059.
31. Chiva-Blanch G., Badimon L. Effects of Polyphenol Intake on Metabolic Syndrome: Current Evidences from Human Trials // Oxidative Medicine and Cellular Longevity. V. 2017. 18 p.
32. Giampieri F., Forbes-Hernandez T. Y., Gasparrini M., Afrin S., Cianciosi D., Reboredo-Rodriguez P., Varela-Lopez A., Quiles J. L., Mezzetti B., Battino M. The healthy effects of strawberry bioactive compounds on molecular pathways related to chronic diseases // Ann. N.Y. Acad. Sci. 2017. V. 1398(1). P. 62-71.
33. Ayoub H. M., McDonald M. R., Sullivan J. A., Tsao R., Platt M., Simpson J., Meckling K. A. The Effect of Anthocyanin-Rich Purple Vegetable Diets on Metabolic Syndrome in Obese Zucker Rats // J Med Food. 2017. Р. 1-10.
34. Bhaswant M., Shafie S. R., Mathai M. L., Mouatt P., Brown L. Anthocyanins in chokeberry and purple maize attenuate diet-induced metabolic syndrome in rats // Nutrition. 2017. V. 9. P. 1261.
35. Chavushyan V. A., Simonyan K. V., Simonyan R. M., Isoyan A. S., Simonyan G. M., Babakhanyan M. A., Hovhannisyian L. E., Nahapetyan Kh. H., Avetisyan L. G., Simonyan M. A. Effects of stevia on synaptic plasticity and NADPH oxidase level of CNS in conditions of metabolic disorders caused by fructose // BMC Complementary and Alternative Medicine. 2017. V. 17. P. 540.
36. Carrera-Lanestosa A., Moguel-Ordo´n˜ez Y., Segura-Campos M. Stevia rebaudiana Bertoni: A Natural Alternative for Treating Diseases Associated with Metabolic Syndrome // J Med Food. 2017. P. 1-11.
Review
For citations:
Povydysh M.N., Luzhanin V.G., Ivkin D.Yu., Belousov M.V., Yakovlev G.P. PROSPECTS OF USING PHYTOTHERAPY AT DISORDERS OF FAT AND CARBOHYDRATE METABOLISM. Drug development & registration. 2018;(3):130-135. (In Russ.)
Views:
849
Email this article 